Search "nicotinamide riboside benefits" and you meet two internets. One promises NR reverses aging, rewinds tired cells, and hands back the energy of your thirties. The other — the peer-reviewed one — is more careful, and far more interesting.
The honest version: In human trials, nicotinamide riboside (NR) does two things reliably — it raises NAD+ levels, and it is well tolerated. What it has not been shown to do is deliver the dramatic, felt anti-aging results the marketing implies. NR is a well-studied NAD+ precursor, not a one-pill answer to aging.
That gap — between "raises a lab marker" and "changes how you feel in five years" — is the whole story of NR. If you are in midlife and weighing an NAD+ supplement, it is also the part most worth understanding before you spend a cent. Here is what the research actually shows, benefit by benefit, with the honest limits attached.
What is nicotinamide riboside, in one paragraph?
Nicotinamide riboside is a form of vitamin B3 that your body converts into NAD+ — nicotinamide adenine dinucleotide, a coenzyme every cell uses to turn food into energy and to run hundreds of metabolic reactions. You do not take NAD+ directly; you take a precursor like NR, and your cells build NAD+ from it. NR is one of the two leading NAD+ precursors on the shelf, alongside NMN, and it is among the best-studied in humans. If you want the deeper chemistry, our explainer on why NAD+ matters → walks through the coenzyme itself.
Why NAD+ — and precursors like NR — became a focus
NAD+ tends to decline with age. A widely cited 2021 review in Nature Reviews Molecular Cell Biology describes how NAD+ availability falls over the lifespan and why that decline became a central question in aging biology.5 That single observation is the reason NAD+ precursors exist as a supplement category: the logic is that if NAD+ drops, topping up the raw material your cells use to make it might help support normal cellular function.
For women in midlife, that window often overlaps with a stretch when energy, sleep, and recovery feel different — which is why NAD+ support has become such a common entry point into cellular wellness. It is worth being precise about the logic, though: "NAD+ declines with age" is well established. "Therefore taking NR will make you feel younger" is the leap the evidence has not yet finished testing.
What the research on NR actually shows
NR is unusual in this category for having several real human trials behind it. Here is what they found — and, just as importantly, what they did not.
1. It raises NAD+ in people. The foundational 2016 study in Nature Communications was the first to show that oral NR is bioavailable in humans and raises the blood NAD+ metabolome.1 That sounds basic, but it mattered: it confirmed the core premise that a precursor on the shelf can actually move NAD+ in a living person, not just in a dish.
2. The increase is meaningful and repeatable. A 2018 randomized trial, also in Nature Communications, gave healthy middle-aged and older adults 1,000 mg of NR per day and reported roughly a 60% increase in NAD+ — with no serious side effects.2 A separate placebo-controlled safety trial found that doses from 100 mg to 1,000 mg per day raised whole-blood NAD+ in a dose-dependent way, with a side-effect profile similar to placebo.3
The number worth remembering: in a controlled human trial, daily NR raised NAD+ by about 60% — and was well tolerated over six weeks.2 That NR raises NAD+ is one of the more settled facts in this field.
3. In aged muscle, it shifted some markers — but not function. This is the most instructive trial of the set. In 2019, researchers gave 12 aged men 1 g of NR daily for three weeks and looked directly at muscle.4 NR raised the muscle NAD+ metabolome and lowered several circulating inflammatory markers. But it did not change mitochondrial bioenergetics — the actual energy-producing performance of the muscle. In plain terms: the supplement moved the biology it was supposed to move, yet the functional payoff did not show up in three weeks. That is the honest shape of NR's evidence in miniature.
Human NR trials at a glance
| Study | What it tested | What it found |
|---|---|---|
| Trammell et al., 20161 | Single doses in humans | Oral NR is bioavailable and raises the blood NAD+ metabolome |
| Martens et al., 20182 | 1,000 mg/day, healthy middle-aged & older adults | ~60% rise in NAD+; well tolerated |
| Conze et al., 20193 | 100–1,000 mg/day, overweight adults | Dose-dependent NAD+ increase; safety similar to placebo |
| Elhassan et al., 20194 | 1 g/day, 3 weeks, aged men (muscle) | Muscle NAD+ and some inflammatory markers shifted; muscle energy output unchanged |
So what do those benefits actually mean for you?
Here is the quotable, accurate summary: the evidence that NR raises NAD+ and is well tolerated is solid; the evidence that those increases produce specific benefits you would feel over months or years is still developing. Both halves of that sentence are true, and most marketing only tells you the first one.
This is not a reason to be cynical about the science. It is a reason to be honest about where it stands. NR clearly does the upstream thing — it feeds the NAD+ pathway. Whether that reliably translates into the energy, recovery, and longevity outcomes people are hoping for is the question the next decade of research has to answer. A supplement can be a reasonable, evidence-informed choice without being a proven one, and NR sits exactly there.
What nicotinamide riboside will not do
This is the part most longevity brands skip, so we will say it plainly. Based on the current evidence, NR will not reverse aging, and it will not treat, cure, or prevent any disease. It will not replace sleep, movement, and decent nutrition — the unglamorous inputs that still do most of the heavy lifting. And it will not deliver guaranteed or overnight results; the trials that show NAD+ moving ran for weeks, and the meaningful question is consistency over time. If a brand promises any of those things — for NR or any precursor — treat it as a red flag, not a selling point.
NR vs NMN: does the precursor matter?
NR and NMN are the two leading NAD+ precursors, and they sit one step apart on the same pathway: NR converts to NMN, which converts to NAD+. So NMN is one step closer to NAD+, while NR currently has a slightly longer human research record. Neither is "better" in the abstract, and there is no head-to-head consumer trial crowning a winner. The quality of the specific product — serving size, purity, third-party testing, an honest label — matters far more than the precursor name on the front. We break the two down without the hype in our NMN vs NR guide →, and if you are curious how NMN's own evidence compares, our look at what the NMN research shows → applies the same honest lens.
Where CELLSHE fits
We will be straight with you: CELLSHE does not sell NR. We focus on the other major NAD+ precursor, NMN, which sits one step closer to NAD+ on the pathway and is the form we built our routine around for women navigating midlife. Our NMN 500 → delivers 500 mg of high-purity β-NMN in a single daily capsule to support NAD+ biosynthesis and cellular energy production,* and the Cellular Trio → builds it into a complete daily ritual — third-party tested, with a certificate of analysis available on request. If you would rather use NR, that is a perfectly credible path. We just made a different, equally honest formulation choice — and we would rather earn your trust than oversell either molecule.
Frequently asked questions
What are the main benefits of nicotinamide riboside?
In human trials, NR's clearest, best-supported effects are that it raises NAD+ levels and is well tolerated at common doses. Other potential benefits — for energy, muscle, or healthy aging over time — are still being studied and should not be treated as established.
How long does NR take to work?
NAD+ levels can rise within days to weeks of daily use in studies. Whether you personally notice anything is individual, and the honest framing is consistency over a 60–90 day window, not an overnight effect.
Is nicotinamide riboside worth taking?
That depends on your goals and budget. NR is a legitimate, well-studied NAD+ precursor, but the research supports "raises NAD+ and is well tolerated" far more strongly than any specific felt benefit. It is a reasonable evidence-informed choice, not a proven one.
Does NR have side effects?
In placebo-controlled trials, NR's side-effect profile was generally similar to placebo at doses up to 1,000 mg per day. Individual responses vary — if you are pregnant or nursing, take medication, or have a health condition, talk to your clinician first.
Is NR or NMN better for NAD+?
Neither is clearly better. They are both NAD+ precursors one step apart on the same pathway, and product quality matters more than the precursor label. See our NMN vs NR guide for the full comparison.
References
- Trammell SAJ, et al. (2016). Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nature Communications. PMID: 27721479. pubmed.ncbi.nlm.nih.gov/27721479
- Martens CR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. PMID: 29599478. pubmed.ncbi.nlm.nih.gov/29599478
- Conze D, Brenner C, Kruger CL. (2019). Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults. Scientific Reports. PMID: 31278280. pubmed.ncbi.nlm.nih.gov/31278280
- Elhassan YS, et al. (2019). Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. Cell Reports. PMID: 31412242. pubmed.ncbi.nlm.nih.gov/31412242
- Covarrubias AJ, et al. (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. PMID: 33353981. pubmed.ncbi.nlm.nih.gov/33353981
